- 4.4Impact Factor
- 8.8CiteScore
- 20 daysTime to First Decision
Diagnosis and Biomarkers for Hematologic Malignancies
This special issue belongs to the section “Cancer Biomarkers“.
Special Issue Information
Dear Colleagues,
In recent decades, a profound transformation has occurred in the diagnostic approach to hematological disorders, transitioning from a traditional morphological assessment to sophisticated molecular profiling, with an increasing emphasis on multidisciplinary diagnostic strategies. A meticulous diagnosis is essential for precise prognostic stratification and optimized therapeutic selection. Although a microscopic examination of tissues, blood and bone marrow remains the critical foundational assessment, contemporary diagnostic frameworks are progressively defining hematological entities through the sophisticated exploration of underlying molecular and genetic disease mechanisms.
This Special Issue, entitled “Diagnosis and Biomarkers for Hematologic Malignancies”, aims to highlight novel diagnostic and prognostic tools that could improve the management and treatment of hematological neoplasms.
Dr. Luis Colomo
Prof. Dr. Francesco Lanza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic malignancies
- diagnosis
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

